[ET Net News Agency, 14 September 2026] HANSOH PHARMA (03692) rose 3.1% to HK$33.74.
It hits an intra-day high of HK$33.74, breaking above the 100-D SMA of HK$33.082, and an intra-day low of HK$32.48. The total shares traded was 2.02 million, with a value of HK$66.77m. The active buy/sell ratio is 68:32, with net buying turnover of HK$23.54m. CHINA INV INFO accounts for greatest net responsive buying turnover of HK$1.28m, with volume weighted average price of HK$32.941. ABN AMRO CLEARING HK accounts for greatest net responsive selling turnover of HK$8.44m, with volume weighted average price of HK$32.985.
The Hang Seng Index now rose 28 points, or 0.1% to 24,834; the Hang Seng China Enterprises Index now rose 5 points, or less than 0.1% to 8,252.
Basic Information| Nominal | 33.740 | % Chg | +3.12% |
| High | 33.740 | Low | 32.480 |
| Shares Tr | 2.02m | Turnover | 66.77m |
| 10-D SMA | 34.864 | %H.V | 66.562 |
| 20-D SMA | 34.226 | VWAP | 33.047 |
| 50-D SMA | 33.260 | RSI14 | 48.718 |
Status: Breaking above the 100-D SMA, active buy/sell ratio is 68:32, with net buying turnover of HK$23.54m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 33.740 | +3.12 |
| SIHUAN PHARM (00460) | 0.720 | Unchanged |
| GRAND PHARMA (00512) | 4.875 | +2.96 |
| SBP GROUP (01177) | 5.445 | +3.71 |
| HENGRUI PHARMA (01276) | 44.600 | +1.92 |
| LIVZON PHARMA (01513) | 20.940 | +0.77 |
| LUYE PHARMA (02186) | 1.825 | +1.39 |
| FOSUN PHARMA (02196) | 16.820 | +3.00 |
| SH PHARMA (02607) | 11.110 | +0.73 |
| CHINARES PHARMA (03320) | 4.285 | +0.82 |
(ed)
